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Objective To study the associations of prenatal blood lead levels
(B-Pb) with pregnancy outcomes in a large cohort of mother–
child pairs in the UK.
Design Prospective birth cohort study.
Setting Avon area of Bristol, UK.
Population Pregnant women enrolled in the Avon Longitudinal
Study of Parents and Children (ALSPAC).
Methods Whole blood samples were collected and analysed by
inductively coupled plasma dynamic reaction cell mass
spectrometry (n = 4285). Data collected on the infants included
anthropometric variables and gestational age at delivery. Linear
regression models for continuous outcomes and logistic regression
models for categorical outcomes were adjusted for covariates
including maternal height, smoking, parity, sex of the baby and
gestational age.
Main outcome measures Birthweight, head circumference and
crown–heel length, preterm delivery and low birthweight.
Results The mean blood lead level (B-Pb) was 3.67  1.47 lg/dl.
B-Pb ≥ 5 lg/dl significantly increased the risk of preterm delivery
(adjusted odds ratio [OR] 1.94, 95% confidence interval [95% CI]
0.27–2.94) but not of having a low birthweight baby (adjusted OR
1.37, 95% CI 0.86–2.18) in multivariable binary logistic models.
Increasing B-Pb was significantly associated with reductions in
birth weight (b 13.23, 95% CI 23.75 to 2.70), head
circumference (b 0.04, 95% CI 0.07 to 0.06) and crown–heel
length (b 0.05, 95% CI 0.10 to 0.00) in multivariable linear
regression models.
Conclusions There was evidence for adverse effects of maternal
B-Pb on the incidence of preterm delivery, birthweight, head
circumference and crown–heel length, but not on the incidence of
low birthweight, in this group of women.
Keywords Birthweight, head circumference, lead, low birthweight,
pregnancy, preterm.
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Introduction
Lead is a neurotoxic metal that is widespread in the envi-
ronment. The removal of lead from water pipes, paint and
food cans, and a ban on lead additives to petrol in most
countries has reduced exposure to lead in recent years,
although industrial activities such as mining, smelting, lead
shot manufacture and battery manufacture and recycling
are still of concern. Food and drink, water, dust and soil
remain as important sources of exposure,1 as does cigarette
smoking.2,3
Lead readily crosses the placenta, with a fetal : maternal
ratio of about 0.7–0.9,4–6 but studies on the association of
blood lead levels in pregnancy and a variety of measures of
birth outcomes, including birthweight (BW), head circum-
ference (HC), gestational age at delivery and preterm deliv-
ery, have had inconsistent results at all levels of exposure.7–11
Poor birth outcomes are known to be associated with poor
developmental trajectories in infancy, as well as having
long-term implications for adult health.12–14 The effects of
lead levels need to be characterised to enable delivery of
appropriate public health policy and individual healthcare to
lead-exposed women and newborn infants.
Previous studies have differed in their findings even in
groups of women who have had high exposure to lead: for
example, Factor-Litvak et al.15 found no effect on birth
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outcomes (BW, length of gestation, preterm delivery)
despite a high blood lead level (B-Pb) of 19.1 lg/dl in
women living near a smelter in Kosovo, whereas McMich-
ael et al.16 found an independent effect on preterm deliv-
ery, but not on low birthweight (LBW), in a similarly
exposed group of women in South Australia (B-Pb
10.6 lg/dl). In women who were not exposed to lead by
their occupation or by nearby industrial processing, the
outcomes have been similarly disparate.8,17–19 As has been
discussed previously by Andrews et al. and Jelliffe-Pawlow-
ski et al.,9,10 this could reflect between-study differences in
sample timing, variation in the mean lead levels and there-
fore the extent of lead exposure, differences in statistical
methods (for example, under- or over-control of covariates,
and choice of categorical or continuous representation of
predictors and outcomes in multiple regression), differences
in sample sizes, and differences in the distributions of pos-
sible effect modifiers in different studies.
The aim of this study was to study the effects of B-Pb
on birth outcomes—LBW, preterm delivery, BW, HC,
crown–heel length (CHL)—in a group of mother–child
pairs in the UK from the Avon Longitudinal Study of Par-
ents and Children (ALSPAC).
Methods
The ALSPAC study
The sample was derived from the ALSPAC study, a popula-
tion-based study investigating environmental and genetic
influences on the health, behaviour and development of
children. This database provided an opportunity to include
a greater number of participants than has been reported on
before and includes a wide range of social and demo-
graphic information to enable the most appropriate selec-
tion of covariates. All pregnant women in the former Avon
Health Authority with an expected delivery date between 1
April 1991 and 31 December 1992 were eligible for the
study; 14 541 pregnant women were enrolled initially,
resulting in a cohort of 14 062 live births.20 The social and
demographic characteristics of this cohort were similar to
those found in UK national census surveys.21 Further
details of ALSPAC are available at www.bris.ac.uk/alspac.
Questionnaires
The mothers received four postal self-completion question-
naires during pregnancy. The questionnaires are available
from the study website.22 Information on environmental
and lifestyle factors included data on age, parity, social
class, highest educational qualification, cigarette smoking,
etc. Data on cigarette smoking were taken from a question-
naire completed at 18 weeks of gestation in response to a
question on the number of cigarettes smoked in the previ-
ous 2 weeks (16–18 weeks of gestation).
Pregnancy outcomes
Newborn HC and CHL were measured by trained study
staff where the mother gave permission (n = 3280, 92.4%;
n = 3224, 92.1%; respectively), or if these data were miss-
ing, the values were extracted from the medical records by
trained study staff (n = 269, 7.6%; n = 275, 7.9%; respec-
tively). BW was derived from obstetric data and from cen-
tral birth notification data: where values disagreed by
<100 g then the lowest value was accepted; if the values
disagreed by >100 g then the value was coded as missing.
Study staff were blinded to the maternal B-Pb. Pre-eclamp-
sia was defined as systolic blood pressure >139 mmHg or
diastolic blood pressure >89 mmHg measured on at least
two occasions after 20 weeks of gestation with simulta-
neous proteinuria (dipstick test at least 1+; Albustix, Ames
Co., Elkhart, IN, USA) (extracted from medical records by
trained study staff). Length of gestation was based on last
menstrual period date, ultrasound assessment or other clin-
ical indicators. Where there was conflict between the
maternal report and ultrasound assessment, an experienced
obstetrician reviewed the clinical records and made a best
estimate.
Collection, storage and analysis of blood samples
Whole blood samples were collected in acid-washed vacu-
tainers (Becton and Dickinson, Oxford, UK) by midwives
as early as possible in pregnancy. Whole blood samples
were stored in the original tube at 4°C at the collection site
before being transferred to the central Bristol laboratory
within 1–4 days. Samples were at ambient temperature
during transfer (up to 3 hours). They were then stored at
4°C until analysis.
Details of the analysis have been reported.23 In brief,
inductively coupled plasma mass spectrometry in standard
mode (R. Jones, Centers for Disease Control, Bethesda,
MD, USA; Method 3009.1) was used to measure blood lev-
els of lead with appropriate quality controls.17
Statistical analysis
Statistical analysis was done with SPSS version 19 (IBM
Corp., Chicago, IL, USA). Values are reported as
mean  SD. Chi-square tests were used to analyse differ-
ences in categorical data, and two-sided t tests and were
used to compare continuous values.
Univariable and multivariable linear regression models
were used to examine the relationship of B-Pb on BW, HC
and CHL. Logistic regression analysis was used to examine
the effect of the binary variables preterm (<37 weeks of
gestation) and LBW (<2500 g). Categories of <5 and
≥5 lg/dl were chosen for the following reasons: (1) the US
Association of Occupational and Environmental Clinics24
recommended in 2007 that B-Pb should be <5 lg/dl
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during pregnancy, and this was endorsed by the recom-
mendations of the US Centers for Disease Control in
201025 and the American College of Obstetricians and
Gynecologists in 2012;26 (2) 5 lg/dl is the cut-off point
recommended by the USA above which monitoring of chil-
dren should be initiated.27 Factors included as confounders
in the models were: maternal height, maternal prepregnan-
cy weight, maternal educational attainment (none/Certifi-
cate of School Education, Vocational, O-levels, A-levels,
degree), parity (0 versus ≥1), gestational age at delivery
(weeks), number of cigarettes smoked per day and sex of
the baby. These factors were broadly in accordance with
those selected by Jelliffe-Pawlowski et al.10 as being consis-
tently associated with BW, length of gestation, fetal growth
retardation and other measures including LBW, preterm
delivery and small-for-gestational-age at birth. However,
unlike Jelliffe-Pawlowski et al.10 we did not include mater-
nal ethnicity in any of the models because of the low num-
bers of ethnic minority participants included in the sample
(non-white 2.4%). We also included smoking and maternal
height and prepregnancy weight as these are also known to
have associations with fetal growth.28,29 The linear regres-
sion analyses were repeated using log10 B-Pb to account for
the skewed distribution of B-Pb. Regression diagnostics
were used to check that the models fitted the observed data
well and to identify any cases that had undue influence on
the model.
Results
The demographics of the subsample of the ALSPAC popu-
lation have been reported previously.2 The subsample
had slightly higher educational attainment (P = 0.004,
chi-square test) and tended to be slightly older (P < 0.001,
chi-square test) than the rest of the ALSPAC sample, but
there were no other strongly statistically significant differ-
ences. The median gestational age at the time of blood
sampling was 11 weeks (range 1–42 weeks, interquartile
range 9–13 weeks). The analyses were completed on 4285
women for lead. One sample had a lead level below the
limit of detection (0.29 lg/dl): this sample was assigned a
value of 0.7 times the lower limit of detection. The mean
maternal B-Pb was 3.67  1.47 lg/dl (n = 4285; geometric
mean 3.43, median 3.42, range 0.41–19.14 lg/dl).2 The
birth outcomes are summarised in Table 1.
No cases were identified as outliers for the linear or the
logistic regression models. BW, HC and CHL were each
strongly significantly negatively linearly associated with
B-Pb (r = 0.074, P < 0.001; r = 0.047, P = 0.006;
r = 0.063, P < 0.001, respectively). B-Pb was not signifi-
cantly greater in mothers delivering LBW (n = 420) versus
not LBW (n = 3849) infants (3.79  1.47 versus
3.65  1.46 lg/dl; P = 0.067, t test), or in those delivering
preterm (n = 216) versus not preterm (n = 2322)
(3.87  1.67 versus 3.67  1.49 lg/dl; P = 0.070, t test).
There was no significant difference in the B-Pb of those
mothers having pre-eclampsia (n = 91) versus no
pre-eclampsia (n = 3976) (3.63  1.22 versus 3.67  1.47;
P = 0.806, t test).
Increasing B-Pb was strongly significantly associated with
reductions in BW, HC and CHL (P < 0.001, P = 0.006 and
P < 0.001, respectively) in univariable linear regression
models (Table 2). These associations were maintained in
multivariable models (P = 0.014, P = 0.021, P = 0.034,
respectively). An increase of 1 lg/dl in B-Pb predicted
decreases in BW, HC and CHL of 13.2 g, 4 mm and
Table 1. Birth outcomes and categorical associations of B-Pb (<5.00 or ≥5.00 lg/dl) with birth outcomes
B-Pb (lg/dl) P value
<5.00 ≥5.00
Gestational age at
delivery (weeks)
39.4  2.1 (n = 4108) 39.4  2.1 (n = 3516) 39.3  2.3 (n = 592) 0.207*
Birthweight (g) 3411  572 (n = 4052) 3424  567 (n = 3469) 3334  595 (n = 583) 0.001*
Head circumference (cm) 35.0  1.5 (n = 3514) 34.8  1.5 (n = 3010) 34.6  1.8 (n = 504) 0.031*
Crown–heel length (cm) 50.7  2.4 (n = 3467) 50.7  2.3 (n = 2970) 50.4  2.6 (n = 497) 0.011*
Low birthweight
(<2500 g), n (%)
420/4269 (9.8%) 346/3654 (9.5%) 74/615 (12.0%) 0.048**
Preterm (<37 weeks),
n (%)
216/2538 (8.5%) 167/2158 (7.7%) 49/380 (12.9%) 0.001**
Data are given as mean  SD unless otherwise stated.
*Unpaired t-test.
**Chi-square test.
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5 mm, respectively. The results were similar to those for
the log values, so the results for non-log values are pre-
sented for ease of interpretation and comparison with other
studies (see Table S1).
In univariable categorical analysis adverse birth outcomes
(LBW and preterm delivery, lower BW, HC and CH) were
strongly significantly associated with B-Pb ≥ 5.00 lg/dl
(P < 0.048, P = 0.001, P = < 0.001, P = 0.021 and
P = 0.011, respectively; t-test or chi-square test) (Table 1).
Maternal B-Pb ≥ 5.00 lg/dl increased the risk of preterm
delivery (adjusted odds ratio 1.94, 95% confidence interval
0.27–2.94) but not of having an LBW infant (adjusted odds
ratio 1.37, 95% confidence interval 0.86–2.18) in multivari-
able logistic multiple regression analysis (Table 3).
Discussion
Main findings
This study provides evidence for adverse effects of maternal
B-Pb on pregnancy outcomes. Based on the premise that
the fetal B-Pb is about 80% of that of the mother, US rec-
ommendations are that maternal B-Pb should be kept
<5 lg/dl;24–26 using this value as a cut-off, we have shown
an increased risk of preterm delivery at maternal levels
≥5.00 lg/dl but there was no effect of maternal B-Pb on
LBW. We have also shown reductions in BW, HC and
CHL with increasing maternal B-Pb.
Strengths and limitations
The strength of our study lies in the large number of preg-
nant women that we were able to include, which would
help to highlight subtle effects. The limitations of our study
were the bias in the sample (women who had B-Pb mea-
surements were older and had higher educational levels
than the rest of the ALSPAC cohort). This would not be
expected to affect the independent results of regression and
logistic models, however. It is likely that maternal B-Pb in
the UK will have fallen further in recent years, although it
is possible that exposure levels may remain relatively high
in the Bristol area of the UK due to a local history of lead
mining and working.2,30 Finally, it should be noted that
this study shows associations only and it is not possible to
take all confounders into account in the models.
Interpretation
The mechanisms by which lead could have an adverse
effect on pregnancy outcomes include an impairment of
fetal bone growth caused by competition with calcium for
deposition into bone,31 reductions in fetal thyroid hor-
mones,32 accumulation of lead in the placenta causing
abnormal placental function and reduced nutrient trans-
fer,33 and oxidative stress.34 Preterm delivery may be
prompted by premature rupture of the membranes through
lead-induced reactive oxygen species causing collagen dam-
age and hence structural weakness.19 There is considerable
controversy in the literature, however, concerning the
effects of maternal B-Pb on pregnancy outcomes, even in
groups of mothers with relatively high exposures to lead
(see Table S2). It has been proposed that these differing
findings result from methodological differences.9,10 These
include differences in the biological material used to mea-
sure the lead level, the timing of the samples, the range of
lead levels in the samples, the timing of any specific lead
exposure, and substantial differences in the methods used
for statistical analysis, including choice of confounders,
under- and over-control of confounders, and the use of
categorical or continuous data. In addition, a range of out-
comes have been chosen, and sample sizes have sometimes
Table 2. Linear regression analysis: B-Pb (lg/dl) as a predictor of
birth outcomes
R2 (%) b (SE) 95% CI for b P value
Birthweight (g)
Univariate 0.7 28.85 (6.10) 40.82 to 16.88 <0.001
Multivariate* 38.7 13.23 (5.37) 23.75 to 2.70 0.014
Head circumference (cm)
Univariate 0.2 0.05 (0.02) 0.08 to 0.01 0.006
Multivariate* 30.9 0.04 (0.16) 0.07 to 0.06 0.021
Crown–heel (cm)
Univariate 0.4 0.10 (0.03) 0.16 to 0.05 <0.001
Multivariate* 32.1 0.05 (0.03) 0.10 to 0.00 0.034
All models overall P < 0.001.
*Adjusted for maternal height, maternal prepregnancy weight,
maternal educational attainment, parity, no. of cigarettes per day, sex
of baby, gestational age at delivery or death.
Table 3. Logistic regression analysis: B-Pb <5 (reference) or ≥5 lg/dl
as a predictor of preterm delivery and of low birthweight
OR 95% CI P value
Preterm (yes)
Univariate 1.77 1.26–2.48 0.001
Multivariate* 1.94 0.27–2.94 0.002
LBW (yes)
Univariate 1.31 1.00–1.71 0.049
Multivariate** 1.37 0.86–2.18 0.187
Preterm, <37 weeks of gestation; low birthweight (LBW), <2500 g.
*Adjusted for maternal height, maternal prepregnancy weight,
maternal educational attainment, parity, no. of cigarettes per day,
sex of baby.
**Adjusted for maternal height, maternal prepregnancy weight,
maternal educational attainment, parity, no. of cigarettes per day,
sex of baby and gestational age at delivery or death.
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been very small (see Table S2). These variations are not
always easy to identify in the literature, which makes com-
parisons of results between different studies difficult.9 To
address as many of these concerns as possible, we were able
to include a large number of pregnant women in our sam-
ple. The median gestational age at which the blood sample
was taken was 11 weeks: as B-Pb are thought to follow a
U-shaped curve during pregnancy,35 this makes comparison
of levels in studies in which blood sample were taken in
the first with the third trimester valid. Following the con-
clusions of Andrews et al.,9 we excluded alcohol intake as a
confounder but included cigarette smoking, and present
our results as univariable and multivariable. We used a set
of confounders that were very similar to those of Jel-
liffe-Pawlowski et al.,10 except that we excluded adjustment
for ethnicity because our sample included very few women
from ethnic minorities.
It might be expected therefore that populations with
high exposure would have the greatest risk of adverse preg-
nancy outcomes: high maternal B-Pb or occupational expo-
sure have been associated with preterm delivery,16
miscarriage,36 small-for-gestational-age babies,37 and effects
on BW and the incidence of neural tube defects.38 How-
ever, other studies have not observed any effects in mothers
with high exposure levels.15,39–41 The findings of studies
where B-Pb were relatively low have been equally disparate.
For example, linear associations with premature delivery,18
and an association with the length of gestation but not
with BW or HC17 have been found at mean B-Pb < 5 lg/dl.
Two recent studies, however, have converged on finding
effects on BW but not on other pregnancy outcomes
despite a large between-study difference in maternal
B-Pb.7,8
The decrease in BW of 13.2 g per increase of 1 lg/dl in
B-Pb found in the present study is greater than has been
reported previously,7,32,42 even though the B-Pb reported in
other studies tended to be higher than that in the present
study (mean B-Pb in present study 3.67  1.47 lg/dl ver-
sus, for example, mean maternal B-Pb 8.9 lg/dl42). How-
ever, it has been suggested that the adverse effects are
relatively greater at lower B-Pb: in a large study (42 288
mother–infant pairs from a US registry) in which only
B-Pb < 10 lg/dl were included, the decrease ranged from
4 g for a change from 9 to 10 lg/dl to 27 g for a change
from 0 to 1 lg/dl.7 These values were stated as being con-
sistent with other studies in which decreases ranging from
0.3 g32 to 6.2 g42 per 1 lg/dl increase in B-Pb were
reported.
The decreases of 4 mm in HC and 5 mm in CHL per
increase of 1 lg/dl in B-Pb found in the present study were
small but nonetheless statistically significant. Associations
of B-Pb with CHL and HC have not generally been found
in previous studies8,11,17,41,43 even when the mean B-Pb was
relatively high,41 although this is not a consistent find-
ing44,45 (see Table S2).
The effects of B-Pb on preterm delivery (or length of
gestation) and LBW (or small-for-gestational-age) are simi-
larly divided in the literature, with some authors reporting
no effect on one or both of the variables,7,8,46,47 and others
reporting linear associations,16,18 or a doubling37 or even
trebling10 of risk for B-Pb > 10 lg/dl (see Table S2). In line
with these findings, but using a lower cut-off level of 5 lg/dl,
we found that the risk of preterm delivery in women with
levels ≥ 5 lg/dl was twice that in women with levels
< 5 lg/dl.
Conclusion
There was an adverse effect of B-Pb on pregnancy out-
comes in this group of women, with reductions in BW,
HC and CHL with increasing B-Pb, and an almost twofold
increased risk of preterm delivery for maternal B-Pb
> 5 lg/dl. LBW was not associated with maternal B-Pb.
These adverse effects may have important long-term effects
on the physical and neurological development of the child
and into adulthood: further work will be undertaken in
the ALSPAC cohort to study the effects of maternal B-Pb
on the growth and development of the child up to
18 years.
Disclosure of interests
None of the authors have any competing interests to
declare.
Contribution to authorship
CMT conceived the study with the collaboration of JG and
AME. CMT undertook the analyses. All authors contrib-
uted to the interpretation of the results. CMT drafted the
article and critical revisions were made by JG and AME.
All authors have approved the final version to be pub-
lished.
Details of ethics approval
Ethics approval for the study was obtained from the
ALPAC Ethics and Law Committee and Local Research
Ethics Committees.
Funding
The UK Medical Research Council and the Wellcome Trust
(Grant ref: 092731), and the University of Bristol, provide
core support for ALSPAC. The assays of the maternal
blood samples were carried out at the Centers for Disease
Control and Prevention with funding from the National
Oceanic and Atmospheric Administration (NOAA). CMT
was supported by a Daphne Jackson Trust Fellowship spon-
sored by the University of Bristol.
5ª 2014 The Authors. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists.
Maternal blood lead levels and birth outcomes
Acknowledgements
We are extremely grateful to all the families who took part
in the study, the midwives for their help in recruiting
them, and the whole ALSPAC team, which includes inter-
views, computer and laboratory technicians, clerical work-
ers, research scientists, volunteers, managers, receptionists
and nurses. We thank S. Gregory for help with data prepa-
ration, R. Jones for laboratory analyses and C. Steer for sta-
tistical advice. The publication is the work of the authors
who will serve as guarantors for the contents of the paper.
Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Table S1. Linear multiple regression: log10 B-Pb (lg/dl)
as predictor of birth outcomes.
Table S2. Summary of studies on associations between
maternal B-Pb and pregnancy outcome.&
References
1 European Food Safety Authority Panel on Contaminants in the Food
Chain. Scientific opinion on lead in food. EFSA J 2010;8:1570–717.
2 Taylor CM, Golding J, Hibbeln J, Emond AM. Enviromental factors in
relation to blood lead levels in pregnant women in the UK: The
ALSPAC study. PLoS One 2013;8:e72371.
3 Chelchowska M, Jablonka-Salach K, Ambroszkiewicz J, Maciejewski
T, Gajewska J, Bulska E, et al. Effect of cigarette smoking on blood
lead levels in pregnant women. Medycyna Wieku Rozwoj
2012;16:196–204.
4 Rudge CV, Rollin HB, Nogueira CM, Thomassen Y, Rudge MC,
Odland JO. The placenta as a barrier for toxic and essential
elements in paired maternal and cord blood samples of South
African delivering women. J Environ Monitor 2009;11:1322–30.
5 Schell LM, Denham M, Stark AD, Gomez M, Ravenscroft J, Parsons
PJ, et al. Maternal blood lead concentration, diet during pregnancy,
and anthropometry predict neonatal blood lead in a
socioeconomically disadvantaged population. Environ Health Persp
2003;111:195–200.
6 Amaral JH, Rezende VB, Quintana SM, Gerlach RF, Barbosa F Jr,
Tanus-Santos JE. The relationship between blood and serum lead
levels in peripartum women and their respective umbilical cords.
Basic Clini Pharmacol Toxicol 2010;107:971–5.
7 Zhu M, Fitzgerald EF, Gelberg KH, Lin S, Druschel CM. Maternal
low-level lead exposure and fetal growth. Environ Health Persp
2010;118:1471–5.
8 Xie X, Ding G, Cui C, Chen L, Gao Y, Zhou Y, et al. The effects of
low-level prenatal lead exposure on birth outcomes. Environ Pollut
2013;175:30–4.
9 Andrews KW, Savitz DA, Hertz-Picciotto I. Prenatal lead exposure in
relation to gestational age and birth weight: A review of
epidemiologic studies. Am J Industr Med 1994;26:13–32.
10 Jelliffe-Pawlowski LL, Miles SQ, Courtney JG, Materna B, Charlton V.
Effect of magnitude and timing of maternal pregnancy blood lead
(Pb) levels on birth outcomes. J Perinatol 2006;26:154–62.
11 Rahman A, Al-Rashidi HA, Khan AR. Association of maternal blood
lead level during pregnancy with child blood lead level and
pregnancy outcome in kuwait. Ecol Food Nutr 2012;51:40–57.
12 Dennison EM, Syddall HE, Sayer AA, Gilbody HJ, Cooper C. Birth
weight and weight at 1 year are independent determinants of bone
mass in the seventh decade: The Hertfordshire cohort study. Pediatr
Res 2005;57:582–6.
13 Gale CR, Martyn CN, Kellingray S, Eastell R, Cooper C. Intrauterine
programming of adult body composition. J Clin Endocrinol Metabol
2000;86:267–72.
14 Barker DJ. The developmental origins of adult disease. Eur J
Epidemiol 2003;18:733–6.
15 Factor-Litvak P, Graziano JH, Kline JK, Popovac D, Mehmeti A,
Ahmedi G, et al. A prospective study of birthweight and length of
gestation in a population surrounding a lead smelter in Kosovo,
Yugoslavia. Int J Epidemiol 1991;20:722–8.
16 McMichael AJ, Vimpani GV, Robertson EF, Baghurst PA, Clark PD.
The Port Pirie cohort study: maternal blood lead and pregnancy
outcome. J Epidemiol Commun Health 1986;40:18–25.
17 Gundacker C, Frohlich S, Graf-Rohrmeister K, Eibenberger B,
Jessenig V, Gicic D, et al. Perinatal lead and mercury exposure in
Austria. Sci Total Environ 2010;408:5744–9.
18 Vigeh M, Yokoyama K, Seyedaghamiri Z, Shinohara A, Matsukawa
T, Chiba M, et al. Blood lead at currently acceptable levels may
cause preterm labour. Occup Environ Med 2011;68:231–4.
19 Vigeh M, Yokoyama K, Shinohara A, Afshinrokh M, Yunesian M.
Early pregnancy blood lead levels and the risk of premature rupture
of the membranes. Reprod Toxicol 2010;30:477–80.
20 Boyd A, Golding J, Macleod J, Lawlor DA, Fraser A, Henderson J,
et al. Cohort profile: The ‘Children of the 90s’ - the index offspring
of the Avon Longitudinal Study of Parents and Children. Int J
Epidemiol 2013;42:111–27.
21 Fraser A, Macdonald-Wallis C, Tilling K, Boyd A, Golding J, Davey
Smith G, et al. Cohort profile: The Avon Longitudinal Study of
Parents and Children: ALSPAC mothers cohort. Int J Epidemiol
2013;42:97–110.
22 Avon Longitudinal Study of Parents and Children. Questionnaires.
[www.bristol.ac.uk/alspac/researchers/resources-available/
data-details/questionnaires/]. Accessed 7 April 2014.
23 Golding J, Steer C, Hibbeln J, Lowery T, Jones R. Dietary predictors
of maternal prenatal blood mercury levels in the ALSPAC birth
cohort study. Env Health Perspect 2013;121:1214–8.
24 Association of Occupational and Environmental Clinics. Medical
management guidelines for lead-exposed adults. Revised 25 April
2007. [www.aoec.org/documents/positions/mmg_final.pdf]. Accessed
7 April 2014.
25 Centers for Disease Control and Prevention. In: Ettinger AS,
Wengrovitz AG, Portier C, Brown MJ, editors. Guidelines for the
identification and management of lead exposure in pregnant
and lactating women. Atlanta, GA: Centers for Disease Control
and Prevention; 2010. [www.cdc.gov/nceh/lead/publications/
LeadandPregnancy2010.pdf]. Accessed 7 April 2014.
26 American College of Obstetricians and Gynecologists. Lead screening
during pregnancy and lactation. Committee opinion number 533.
2012. [www.acog.org/~/media/Committee%20Opinions/Committee%
20on%20Obstetric%20Practice/co533.pdf?dmc=1&ts=20131007T04
12098105]. Accessed 7 April 2014.
27 Centers for Disease Control and Prevention. What do parents need
to know to protect their children?, 2012. [http://www.cdc.gov/nceh/
lead/ACCLPP/blood_lead_levels.htm]. Accessed 7 April 2014.
28 Leonardi-Bee J, Smyth A, Britton J, Coleman T. Environmental
tobacco smoke and fetal health: systematic review and
meta-analysis. Arch Dis Child 2008;93:F351–61.
29 Catalano PM, Ehrenberg HM. The short- and long-term implications
of maternal obesity on the mother and her offspring. BJOG
2006;113:1126–33.
6 ª 2014 The Authors. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists.
Taylor et al.
30 Taylor CM, Golding J, Emond AM. Lead, cadmium and mercury
levels in pregnancy: the need for international consensus on levels
of concern. J Dev Origins Health Dis 2014;5:16–30.
31 Potula V, Henderson A, Kaye W. Calcitropic hormones, bone
turnover, and lead exposure among female smelter workers. Arch
Environ Occup Health 2005;60:195–204.
32 Zentner LE, Rondo PH, Mastroeni SS. Lead contamination and
anthropometry of the newborn baby. J Trop Pediatr 2006;52:369–
71.
33 Llanos MN, Ronco AM. Fetal growth restriction is related to
placental levels of cadmium, lead and arsenic but not with
antioxidant activities. Reprod Toxicol 2009;27:88–92.
34 Masso EL, Corredor L, Antonio MT. Oxidative damage in liver after
perinatal intoxication with lead and/or cadmium. J Trace Elem Med
Biol 2007;21:210–16.
35 Hertz-Picciotto I, Schramm M, Watt-Morse M, Chantala K, Anderson
J, Osterloh J. Patterns and determinants of blood lead during
pregnancy. Am J Epidemiol 2000;152:829–37.
36 Borja-Aburto VH, Hertz-Picciotto I, Rojas Lopez M, Farias P, Rios C,
Blanco J. Blood lead levels measured prospectively and risk of
spontaneous abortion. Am J Epidemiol 1999;150:590–7.
37 Chen PC, Pan IJ, Wang JD. Parental exposure to lead and
small for gestational age births. Am J Industr Med 2006;49:417–
22.
38 Irgens A, Kruger K, Skorve AH, Irgens LM. Reproductive outcome in
offspring of parents occupationally exposed to lead in Norway. Am J
Industr Med 1998;34:431–7.
39 Mirghani Z. Effect of low lead exposure on gestational age, birth
weight and premature rupture of the membrane. J Pakistan Med
Assoc 2010;60:1027–30.
40 Philion JJ, Schmitt N, Rowe J, Gelpke PM. Effect of lead on fetal
growth in a Canadian smelter city, 1961–1990. Arch Environ Health
1997;52:472–5.
41 Rahman A, Hakeem A. Blood lead levels during pregnancy and
pregnancy outcome in Karachi women. J Pakistan Med Assoc.
2003;53:529–33.
42 Gonzalez-Cossio T, Peterson KE, Sanin LH, Fishbein E, Palazuelos E,
Aro A, et al. Decrease in birth weight in relation to maternal
bone-lead burden. Pediatrics 1997;100:856–62.
43 Falcon M, Vinas P, Luna A. Placental lead and outcome of
pregnancy. Toxicology 2003;185:59–66.
44 Osman K, Akesson A, Berglund M, Bremme K, Schutz A, Ask K,
et al. Toxic and essential elements in placentas of Swedish women.
Clin Biochem 2000;33:131–8.
45 Hernandez-Avila M, Peterson KE, Gonzalez-Cossio T, Sanin LH, Aro
A, Schnaas L, et al. Effect of maternal bone lead on length and
head circumference of newborns and 1-month-old infants. Arch
Environ Health 2002;57:482–8.
46 Bellinger D, Leviton A, Rabinowitz M, Allred E, Needleman H,
Schoenbaum S. Weight gain and maturity in fetuses exposed to low
levels of lead. Environ Res 1991;54:151–8.
47 Sowers M, Jannausch M, Scholl T, Li W, Kemp FW, Bogden JD.
Blood lead concentrations and pregnancy outcomes. Arch Environ
Health 2002;57:489–95.
7ª 2014 The Authors. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists.
Maternal blood lead levels and birth outcomes
